STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns.
